Insel Gruppe AG, University Hospital Bern: Parkinson Disease trials
The registry lists 10 Parkinson Disease studies with Insel Gruppe AG, University Hospital Bern as lead sponsor. 6 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's DiseaseRecruitingNCT07777419Not applicable
- Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior DisorderRecruitingNCT06629207Not applicable
- Acceptability of the Somnomat Casa for the Treatment of Parkinson's DiseaseRecruitingNCT06386497Not applicable
- SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's DiseaseRecruitingNCT05765110Not applicable
- REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech AnalysisRecruitingNCT05182892Not applicable
- International Validation of Two Non-motor Scales in PD (NFS and SPARK)RecruitingNCT04366804
- Psychological Effects of Levodopa in Parkinson's DiseaseCompletedNCT05119075Not applicable
- Objective Assessment of Behavioural Disorders in PDActive, not recruitingNCT04611581
- Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's DiseaseCompletedNCT04578678
- Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIMTerminatedNCT02823158Not applicable